Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III)
D032962:Consent Forms; D032982:Contracts; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D015507:Drugs, Investigational; D004467:Economics; D015673:Fatigue Syndrome, Chronic; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007603:Jurisprudence; D016365:Liability, Legal; D011897:Random Allocation; D012106:Research; D035842:Research Subjects; D012926:Social Control, Formal; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration
Ampligen; Biomedical and Behavioral Research; Dahl v. HEM Pharmaceuticals; Legal Approach